Bahandianon, Feleciano D.
HRN: 15-12-36 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/13/2023
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
02/13/2023
02/20/2023
PO
100,000IU
BID
Oral Thrush
Waiting Final Action
Indication: Empiric Type of Infection: Eye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes